knowledge -WSS

knowledge

author：knowledge 2025-10-02 22:12:40 - browse：14191

Silver Apple Watch — Charles Rex Arbogast/AP

Rune Labs, maker of an Apple Watch app that can track symptoms related to Parkinson’s disease, announced Thursday $12 million in funding led by Nexus NeuroTech, a new venture capital fund focused on brain disorders.

Rune in 2022 received Food and Drug Administration clearance for StrivePD, an Apple Watch app that uses the device’s sensors to track two Parkinson’s-related symptoms: tremors and dyskinesia, or the involuntary movements that are a side effect of medication. The app also collects sleep, activity, and medication data and can serve as a focal point for education and care management for people with Parkinson’s. The app can help users make day-to-day decisions about lifestyle and medication and help inform care decisions by providers. Rune also works with drug companies developing treatments for the disease.

Rune Labs CEO Brian Pepin told STAT the company will use the funds to push the adoption of its technology among health plans that can use it to manage care for their members with Parkinson’s disease. The company last year finalized a deal with “a large California health system” and now hopes to go out and sell to more organizations that have Medicare Advantage plans or other at-risk populations they serve. This requires an investment in business development staff and people to manage those relationships.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Mike Pence clashes with Tucker Carlson in Iowa

focus

WSS

Congress: Eradicate hepatitis C and reduce the deficit

A biotech analyst on neuroscience, placebo effect, not over

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

Police still searching for prisoner who escaped from NYC hospital

Wegovy trial has doctors encouraged over new possibilities

Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

focus

knowledge

focus

Cancer drug shortages should be causing more outrage

Who gets to use the title 'doctor'?

Bright Health sells Medicare Advantage business to Molina

Eli Lilly to acquire Versanis in heated race for weight loss drugs

State Dept. review finds Biden bears some blame for Afghanistan failures

J&J expands global access to TB drug amid advocacy campaign

Novavax promises a turnaround & Lilly roils the obesity market

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

What does generative AI mean for health care? We asked experts

Mike Pence clashes with Tucker Carlson in Iowa

leisure time

Methadone doses haven’t kept up in the age of fentanyl

A biotech analyst on neuroscience, placebo effect, not over

Georgia court denies Trump's request to quash DA's 2020 election probe

Woman gored by Bison at Yellowstone

What to know about Virgin Galactic's 1st mission taking paying customers to space

Why failed clinical trials don’t always spell doom for a new drug

leisure time

focus

hotspot

knowledge